Skip to content

PP&E (Net) at other companies

Eli Lilly logo
Eli LillyLLY
$26.54B+43.7%
Amgen logo
AmgenAMGN
$8.22B+23.0%
Altimmune logo
AltimmuneALT
$208K-45.8%
Wave Life Sciences logo
Wave Life SciencesWVE
$7.08M-26.0%
Prime Medicine logo
Prime MedicinePRME
$18.82M-24.6%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$212K-74.0%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's PP&E (net)?
Vivani Medical (VANI) reported PP&E (net) of $2.75M in Q1 2026.
How has Vivani Medical's PP&E (net) changed year-over-year?
Vivani Medical's PP&E (net) increased by 71.0% year-over-year, from $1.61M to $2.75M.
What is the long-term trend for Vivani Medical's PP&E (net)?
Over 5 years (2020 to 2025), Vivani Medical's PP&E (net) has grown at a 75.3% compound annual growth rate (CAGR), from $174K to $2.88M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.